Literature DB >> 28210827

Medical Conditions and Demographic, Service and Clinical Factors Associated with Atypical Antipsychotic Medication Use Among Children with An Autism Spectrum Disorder.

Johanna K Lake1,2, Danica Denton3, Yona Lunsky4,5, Amy M Shui6, Jeremy Veenstra-VanderWeele7,8, Evdokia Anagnostou9,10.   

Abstract

This study aimed to describe rates of antipsychotic medication use and the association between their use and demographics, clinical variables, and the use of behavioral/education services among children with ASD. For children with ASD ages 2-11 (n = 4749) and those 12-17 (n = 401), 5.4 and 17.7% were prescribed at least one atypical antipsychotic medication respectively. In the multivariable model of young children, older age, use of multiple psychotropic medications, prior ASD diagnosis, non-white Hispanic race/ethnicity, and oppositional defiant problems were associated with antipsychotic use. Among older children, only older age was associated with antipsychotic use. In at least one age group, antipsychotic medication use was also related to behaviour, family and occupational therapy, public insurance, site region, externalizing problems, body mass index, and sleep and gastrointestinal problems.

Entities:  

Keywords:  Atypical antipsychotic medication; Autism spectrum disorder; Children

Mesh:

Substances:

Year:  2017        PMID: 28210827     DOI: 10.1007/s10803-017-3058-8

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  27 in total

1.  Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder.

Authors:  Thomas W Frazier; Paul T Shattuck; Sarah Carter Narendorf; Benjamin P Cooper; Mary Wagner; Edward L Spitznagel
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-12-13       Impact factor: 2.576

Review 2.  Psychopharmacology of autism spectrum disorders.

Authors:  Gabriel Kaplan; James T McCracken
Journal:  Pediatr Clin North Am       Date:  2012-02       Impact factor: 3.278

3.  Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008.

Authors:  Rebecca E Rosenberg; David S Mandell; Janet E Farmer; J Kiely Law; Alison R Marvin; Paul A Law
Journal:  J Autism Dev Disord       Date:  2010-03

4.  Side effects from use of one or more psychiatric medications in a population-based sample of children and adolescents.

Authors:  Robert J Hilt; Monica Chaudhari; Janice F Bell; Christine Wolf; Kent Koprowicz; Bryan H King
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-02-07       Impact factor: 2.576

5.  Effectiveness of medication combined with intensive behavioral intervention for reducing aggression in youth with autism spectrum disorder.

Authors:  Thomas W Frazier; Eric A Youngstrom; Travis Haycook; Aletta Sinoff; Francine Dimitriou; Julie Knapp; Leslie Sinclair
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-06       Impact factor: 2.576

6.  The Children's Sleep Habits Questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children.

Authors:  J A Owens; A Spirito; M McGuinn
Journal:  Sleep       Date:  2000-12-15       Impact factor: 5.849

Review 7.  Management of children with autism spectrum disorders.

Authors:  Scott M Myers; Chris Plauché Johnson
Journal:  Pediatrics       Date:  2007-10-29       Impact factor: 7.124

8.  Randomized, single-blind, controlled trial of a specialist behavior therapy team for challenging behavior in adults with intellectual disabilities.

Authors:  Angela Hassiotis; Dan Robotham; Anton Canagasabey; Renee Romeo; Diane Langridge; Robert Blizard; Shahed Murad; Michael King
Journal:  Am J Psychiatry       Date:  2009-08-17       Impact factor: 18.112

Review 9.  Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder.

Authors:  Fred Volkmar; Matthew Siegel; Marc Woodbury-Smith; Bryan King; James McCracken; Matthew State
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-02       Impact factor: 8.829

Review 10.  Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns.

Authors:  Benedetto Vitiello; Christoph Correll; Barbara van Zwieten-Boot; Alessandro Zuddas; Mara Parellada; Celso Arango
Journal:  Eur Neuropsychopharmacol       Date:  2009-05-24       Impact factor: 4.600

View more
  4 in total

1.  The pursuit of the magic pill: the overuse of psychotropic medications in children with intellectual and developmental disabilities in the USA.

Authors:  J L McLaren; J D Lichtenstein
Journal:  Epidemiol Psychiatr Sci       Date:  2018-10-24       Impact factor: 6.892

Review 2.  The role of drugs in the treatment of autism.

Authors:  Melanie Turner
Journal:  Aust Prescr       Date:  2020-12-01

Review 3.  Gender Trends in Psychotropic Medication Use in Autism.

Authors:  Christopher R Huber; Zachary Fanaro; Varun Soti
Journal:  Cureus       Date:  2022-06-30

4.  A Retrospective Chart Review of Factors Impacting Psychotropic Prescribing Patterns and Polypharmacy Rates in Youth with Autism Spectrum Disorder during the COVID-19 Pandemic.

Authors:  Evan Taniguchi; Kerry Conant; Kylie Keller; Soo-Jeong Kim
Journal:  J Clin Med       Date:  2022-08-18       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.